For selected applicants, the agency plans to cut review times down to one to two months and provide "tumor board-style" ...

NEW YORK – BioNTech will lay off 63 employees and will discontinue cell therapy manufacturing at its plant in Gaithersburg, Maryland by the end of the year, the company said this week. These changes ...

NEW YORK – Researchers at the Cambridge University Hospital and The Royal Marsden Hospital in London have begun enrolling patients with malignant brain tumors into two genomically informed treatment ...

The agency maintains that the beta-amyloid-targeting drugs show too limited benefit to justify their cost to the National Health Service.

Archeus hopes to begin a Phase I trial of the PSMA-targeted agent in metastatic, castration-resistant prostate cancer later this year.

NEW YORK – Lyell Immunopharma announced new clinical data Tuesday from a Phase I/II trial of its dual-targeted CD19/CD20 CAR T-cell therapy for relapsed or refractory large B-cell lymphoma. The ...

In the growing rare disease precision medicine market, drug companies must avoid funding genetic testing that the Justice ...

NEW YORK – Singapore's Ministry of Health announced this week it will launch a genetic testing program to improve diagnosis of familial hypercholesterolemia (FH) as part of a broader national focus on ...

Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...